Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
World J Surg ; 47(10): 2568-2577, 2023 10.
Artigo em Inglês | MEDLINE | ID: mdl-37266699

RESUMO

BACKGROUND: Simultaneous bilateral thoracoscopic lung resection (SBTLR) has been shown to be a feasible and efficacious approach for a wide range of pulmonary conditions. Our aim was to evaluate the impact of different procedures on surgical outcomes in patients receiving SBTLR. METHODS: Between 2012 and 2021, 207 patients with bilateral lung neoplasms who underwent SBTLR were retrospectively reviewed. Fifty-one patients received ipsilateral plus contralateral lobectomy or sublobectomy (lobar group), whilst 156 patients received bilateral sublobectomy (sublobar group). Propensity scores were calculated and matched. Perioperative and clinicopathologic outcomes were compared. RESULTS: The lobar group had a greater mean age (64.5 vs. 60.0 years, p = 0.008), longer operative time (254 vs. 205 min, p < 0.001), and more blood loss (74 vs. 46 ml, p < 0.001). The sublobar group had fewer complications (6.4 vs. 19.6%, p = 0.006), shorter hospital stay (4.8 vs. 7.4 days, p < 0.001), and lower hospital costs (p = 0.03). Among 50 pairs of matched groups, significant differences were found only in operative time, hospital stay, and costs. Maximum tumor size and pathological features differed significantly before and after matching (all p < 0.05), with the lobar group consistently demonstrating a larger main tumor (median, 2.5 cm) and a higher percentage of primary lung cancer (84%). Multivariate logistic regression analysis showed that a longer operative time was the factor associated with more complications (OR: 1.01; 95% CI 1.00-1.02, p = 0.002). CONCLUSIONS: With regard to SBTLR, our data suggests that sublobectomy may reduce the prolonged recovery, hospital costs, and complications incurred by lobectomy, without compromising oncological outcomes.


Assuntos
Carcinoma Pulmonar de Células não Pequenas , Neoplasias Pulmonares , Humanos , Carcinoma Pulmonar de Células não Pequenas/cirurgia , Estudos Retrospectivos , Pneumonectomia/métodos , Neoplasias Pulmonares/cirurgia , Neoplasias Pulmonares/patologia , Pulmão/cirurgia , Estadiamento de Neoplasias
3.
Thorac Cardiovasc Surg ; 71(2): 121-129, 2023 03.
Artigo em Inglês | MEDLINE | ID: mdl-35279816

RESUMO

BACKGROUND: Resection is the current treatment of choice for resectable bilateral pulmonary metastases. This study aimed to compare the differences in outcomes between simultaneous bilateral open and video-assisted thoracic surgery (VATS) for pulmonary metastasectomy. METHODS: Forty-three patients underwent pulmonary metastasectomy through one-stage bilateral open thoracotomy (n = 16) and VATS (n = 27) between 2011 and 2020. Perioperative and oncological data were analyzed. RESULTS: The predominant primary tumor histology in both groups was colorectal cancer. The operative time, blood loss, and pain score on postoperative day 1 (POD1) were higher in the open group (p < 0.001, 0.009, and 0.03, respectively). No significant differences in pain score on POD2 and POD3, postoperative length of stay, or complications were found. Notably, numbers of the resected metastatic lung nodules were significantly greater in the open group (median number: 9.5 vs. 3, p < 0.001). Recurrence-free survival (RFS) and overall survival (OS) were comparable. The median RFS was 15 months (interquartile range [IQR], 6-22) in the open group and 18 months (IQR, 8-47) in the VATS group. The median OS was 28 months (IQR, 14-44) and 29 months (IQR, 15-54) in the open group and VATS group, respectively. CONCLUSION: One-stage bilateral pulmonary metastasectomy is safe and reduces medical expenditures in selected patients regardless of surgical approach. Although the open group harbored a greater number of metastatic foci, perioperative and oncological outcomes were similar to that of the VATS group.


Assuntos
Neoplasias Colorretais , Neoplasias Pulmonares , Metastasectomia , Humanos , Cirurgia Torácica Vídeoassistida/efeitos adversos , Resultado do Tratamento , Metastasectomia/efeitos adversos , Estudos Retrospectivos , Neoplasias Colorretais/patologia , Pneumonectomia/efeitos adversos , Toracotomia/efeitos adversos , Dor/cirurgia
4.
J Clin Med ; 11(8)2022 Apr 18.
Artigo em Inglês | MEDLINE | ID: mdl-35456345

RESUMO

There is a lack of data comparing postoperative pain after subxiphoid and intercostal video-assisted thoracoscopic surgery (VATS). Pain is an individual's subjective experience and, therefore, difficult to compare between different individuals subjected to either procedure. This study assessed reported pain at six postoperative time points in the same patients receiving both subxiphoid and intercostal incisions for thoracic disease. Data from 44 patients who received simultaneous combined intercostal and subxiphoid VATS were retrospectively analyzed from August 2019 to July 2021. All patients received the same length of subxiphoid and intercostal incisions with or without drain placements. A numerical pain rating scale was administered on postoperative days (POD)-1, POD-2, POD-Discharge, POD-30, POD-90, and POD-180. Bilateral uniportal VATS was performed in 11 patients, and unilateral multiportal VATS was performed in 33 patients. In the unilateral VATS group, there were no differences in pain reported for both incisions in the early postoperative period. However, in the bilateral VATS group, subxiphoid wounds resulted in significantly higher pain scores on POD-1, POD-2, and POD-Discharge (p = 0.0003, 0.001, and 0.03, respectively). Higher late (3 and 6 months) postoperative pain was associated with intercostal incisions in both groups, as previously reported, whereas higher early (day 1, 2, and discharge) postoperative pain was more associated with subxiphoid incisions than intercostal incisions in the bilateral VATS group.

5.
Cardiol J ; 28(6): 941-953, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34355776

RESUMO

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease 2019 [COVID-19]) pandemic has presently stunted the growth of the airline industry. Despite the setbacks, pre-COVID-19 passenger numbers are forecasted to return by as early as 2024. As the industry recovers, the number of long-distance flights will surely continue to increase like it did before the pandemic. The incidence of venous thromboembolism (VTE) following air travel is also likely to increase. Although not common, the unique environment of air travel exposes individuals with particular health conditions to an elevated risk of acquiring VTEs. Numerous factors increasing the risk of developing VTE related to air travel have been identified, including inherited and acquired flight-related aspects. Non-pharmacological approaches to reduce air travel-related VTEs involve simple foot movements, compression socks and stockings, intermittent pneumatic compression devices, a novel modified airline seat, and foot exercisers. Pharmacological methods include heparins and direct oral anticoagulants. More than 30 reliable articles were evaluated to present the current knowledge regarding air travel-related VTEs, their risk factors, and prophylactic methods. Issues in research methodologies found in the literature were identified and discussed. Further research involving international collaboration projects is recommended. The authors' perspectives regarding long flights in previously infected COVID-19 individuals are also included.


Assuntos
COVID-19 , Trombose Venosa , Humanos , Fatores de Risco , SARS-CoV-2 , Viagem , Doença Relacionada a Viagens , Trombose Venosa/epidemiologia , Trombose Venosa/prevenção & controle
6.
Thorac Cancer ; 12(9): 1461-1464, 2021 05.
Artigo em Inglês | MEDLINE | ID: mdl-33724695

RESUMO

Very little data exists on salvage surgery in previously unresectable or metastatic disease treated with initial immunotherapy. Only a handful of case reports/series regarding surgery for advanced lung cancer after immunotherapy mention the technical challenges involved. We report the case of a 67-year-old female with a left lung squamous cell lung cancer revealed by computed tomography-guided biopsy. Treatment started with chemotherapy followed by immunotherapy in which a partial response was recorded. Subsequent salvage lingulectomy with the thoracoscopic approach was performed. The patient fully recovered and shows no sign of recurrence at follow-up 16 months on. Our case discusses the surgical tactics involved in the procedure, highlights similar findings encountered in the literature, and contributes to the few reports therein.


Assuntos
Imunoterapia/métodos , Neoplasias Pulmonares/tratamento farmacológico , Neoplasias Pulmonares/cirurgia , Mastectomia Segmentar/métodos , Pneumonectomia/métodos , Toracoscopia/métodos , Idoso , Feminino , Humanos , Neoplasias Pulmonares/patologia
7.
Arq. bras. oftalmol ; 63(1): 29-31, jan.-fev. 2000. tab, graf
Artigo em Português | LILACS | ID: lil-289972

RESUMO

Analizar o resultado visual e as complicaçöes dos 100 primeiros olhos submetidos á facoemulsificaçäo, realizados no Hospital do Servidor Público Estadual Säo Paulo (HSPE), por cirurgiöes iniciantes nesta técnica. Pacientes e Método: As 100 primeiras cirurgias de facoemulsificaçäo realizadas por 05 cirurgiöes, em pacientes do ambulatório de Catarata do HSPE, foram analisadas. A técnica utilizada foi incisäo tunelizada, capsulorrexis curvilínea contínua anterior, facoemulsificaçäo do núcleo, usando um aparelho de bomba peristáltica, e implante de lente intra-ocular, sob anestasia com bloqueio peribulbar. Resultados: As complicaçöes ocorreram em 15,2 por cento dos olhos, sendo rotura de cápsula posterior sem perda vítrea em 8,7 por cento, perda vítrea em 5,4 por cento e luxaçäo de núcleo no vítreo em 1 olho. Em 96,7 por cento dos olhos foram implantados LIO de c


Assuntos
Humanos , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Catarata/epidemiologia , Facoemulsificação/efeitos adversos , Incidência , Acuidade Visual
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...